Financial Performance - Revenues for Q1 2025 were 20,175million,adecreaseof7.721,847 million in Q1 2024[13] - Gross profit for Q1 2025 was 1,180million,down291,659 million in Q1 2024[13] - Net earnings attributable to Archer-Daniels-Midland Company were 295million,adeclineof59.6729 million in the same quarter last year[13] - Basic earnings per share decreased to 0.61inQ12025from1.42 in Q1 2024, representing a drop of 57.3%[13] - Total comprehensive income attributable to Archer-Daniels-Midland Company was 175millioninQ12025,downfrom646 million in Q1 2024[14] - Other income - net for the three months ended March 31, 2025, was (19)million,adecreasefrom(26) million in the same period in 2024[152] - The company reported a total asset impairment, exit, and restructuring costs of 38millionforthethreemonthsendedMarch31,2025,comparedto18 million in the same period of 2024[176] Assets and Liabilities - Total current assets increased slightly to 27,882millionasofMarch31,2025,comparedto27,718 million at the end of 2024[16] - Cash and cash equivalents rose to 864millionfrom611 million at the end of 2024, an increase of 41.3%[16] - As of March 31, 2025, total cash, cash equivalents, restricted cash, and restricted cash equivalents amounted to 4,056million,adecreasefrom4,845 million as of March 31, 2024[29] - The fair value of total assets as of March 31, 2025, was 10,308million,withinventoriescarriedatmarketvaluedat7,021 million[72] - The fair value of the Company's long-term debt was 7.2billionasofMarch31,2025,comparedtoacarryingvalueof7.6 billion[134] - The Company had lines of credit totaling 12.4billionasofMarch31,2025,with7.6 billion remaining unused[135] Segment Performance - The Ag Services and Oilseeds segment generated 17,219millionintotalrevenues,contributingsignificantlytotheoverallrevenue[55]−TheCarbohydrateSolutionssegmentreportedrevenuesof2,683 million, with starches and sweeteners accounting for 2,156million[55]−TheNutritionsegmentachievedtotalrevenuesof1,836 million, with human and animal nutrition contributing 964millionand872 million, respectively[55] - Segment operating profit for the Ag Services and Oilseeds segment was 412million,CarbohydrateSolutionswas240 million, and Nutrition was 95million,totaling747 million in segment operating profit[162] - The company’s operations are organized into three reportable segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition, with each segment evaluated based on operating profit[153] Cash Flow and Investments - Net cash used in operating activities was (342)millioninQ12025,comparedto700 million provided in Q1 2024[18] - Capital expenditures for Q1 2025 were 291million,downfrom328 million in Q1 2024[18] - The Company’s investment in Wilmar International Limited had a carrying value of 3.6billionasofMarch31,2025,withamarketvalueof3.5 billion[41] - The Company executed cross-currency swaps with an aggregate notional amount of 411millionandforeignexchangeforwardstotaling2.4 billion as of March 31, 2025[122] Shareholder Returns - The company paid dividends of 0.51pershareinQ12025,slightlyupfrom0.50 per share in Q1 2024[13] - The Company had approximately 235.7 million shares of common stock in treasury, valued at 4.8billionasofMarch31,2025[140]−TheCompanyhasasharerepurchaseprogramwith115millionsharesremainingtoberepurchaseduntilDecember31,2029[145]RestructuringandCostManagement−Thecompanyannouncedarestructuringprogramexpectedtodeliverover500 million in cost savings by fiscal 2029, with restructuring charges of 23millioninQ12025[179]−ArestructuringprogramannouncedonFebruary4,2025,isexpectedtodeliverover500 million in annual cost savings by fiscal 2029 through various initiatives[205] - The Company intends to prioritize operational excellence and targeted cost reductions, including optimizing operating leverage within the Nutrition segment[202] Legal and Regulatory Matters - The Company is facing multiple class action lawsuits alleging damages between approximately 500milliontoover2.0 billion due to alleged price manipulation in ethanol derivatives[190] - The Company is under investigation by the SEC and DOJ regarding intersegment sales, and it is cooperating with these investigations[192][206] - The Company has identified a material weakness in its internal control over financial reporting related to segment disclosures[207] Market and Economic Conditions - The Company operates in approximately 78 countries, with local currencies as functional currencies for most subsidiaries, impacting revenue and expense translations[210] - The Nutrition segment's revenue changes may not correlate with cost changes, making margin rates a key performance indicator[209] - The Company aims to enhance returns on invested capital through strategic simplification and targeted growth investments[202]